Clinical Trial Update: Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetics and safety of the oral decitabine and cedazuridine combination in cancer patients with renal impairment, sponsored…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Decitabine/Cedazuridine (oral) (decitabine/cedazuridine)

Snippet

Sponsor: Taiho Oncology, Inc. | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 1 | Status: RECRUITING